{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:13:53Z","timestamp":1778728433182,"version":"3.51.4"},"reference-count":6,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001697","name":"Keio University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001697","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K15693"],"award-info":[{"award-number":["22K15693"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K10606"],"award-info":[{"award-number":["24K10606"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jns.2026.125927","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T16:15:28Z","timestamp":1776442528000},"page":"125927","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Reply: Intention-to-treat analysis, MOH remission, and mechanistic insights: Reframing the 12-month CGRP mAb experience"],"prefix":"10.1016","volume":"486","author":[{"given":"Shungo","family":"Imai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiya","family":"Ohtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narumi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chisato","family":"Iba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Ishizuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoko","family":"Hori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsubasa","family":"Takizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2026.125927_bb0005","doi-asserted-by":"crossref","first-page":"125898","DOI":"10.1016\/j.jns.2026.125898","article-title":"Intention-to-treat reality, MOH reversion, and mechanistic insights: reframing the 12-month CGRP mAb experience","volume":"485","author":"Chen","year":"2026","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2026.125927_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2026.125751","article-title":"A 12-month observational study on the safety, efficacy on migraine-associated symptoms and satisfaction of CGRP monoclonal antibodies in Japanese patients with migraine","volume":"481","author":"Imai","year":"2026","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2026.125927_bb0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s10194-024-01737-y","article-title":"CGRP-monoclonal antibodies in Japan: insights from an online survey of physician members of the Japanese headache society","volume":"25","author":"Takizawa","year":"2024","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.jns.2026.125927_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2023.120811","article-title":"Switching between anti-calcitonin gene-related peptide monoclonal antibodies: a comparison of monthly and quarterly dosing","volume":"453","author":"Ihara","year":"2023","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2026.125927_bb0025","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s10072-021-05426-5","article-title":"Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache","volume":"43","author":"Pensato","year":"2022","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jns.2026.125927_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2026.125802","article-title":"A reply: pathophysiological, methodological, and statistical considerations in CGRP monoclonal antibody therapy: a comment on Imai et al","author":"Imai","year":"2026","journal-title":"J. Neurol. Sci."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26002091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26002091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:00:11Z","timestamp":1778727611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X26002091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":6,"alternative-id":["S0022510X26002091"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2026.125927","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reply: Intention-to-treat analysis, MOH remission, and mechanistic insights: Reframing the 12-month CGRP mAb experience","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2026.125927","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2026.125898","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"125927"}}